Endocrine Society RPHR
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this book
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ormandy, C. J.
Right arrow Articles by Kelly, P. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ormandy, C. J.
Right arrow Articles by Kelly, P. A.
Recent Progress in Hormone Research 58:297-323 (2003)
© 2003 The Endocrine Society

Investigation of the Transcriptional Changes Underlying Functional Defects in the Mammary Glands of Prolactin Receptor Knockout Mice

Christopher J. Ormandy*, Matthew Naylor*, Jessica Harris*, Fiona Robertson*, Nelson D. Horseman{dagger}, Geoffrey J. Lindeman{ddagger}, Jane Visvader{ddagger} and Paul A. Kelly

* Cancer Research Program, Garvan Institute of Medical Research, Darlinghurst 2010 Australia
{dagger} Department of Molecular and Cellular Physiology, University of Cincinnati, Cincinnati, Ohio 45267-0576
{dagger} The Walter and Eliza Hall Institute of Medical Research, Royal Melbourne Hospital, Melbourne, Victoria 3050 Australia
Institut National de la Santé et de la Recherche Médicale (INSERM) Unité 344, Faculté de Médecine Hopital Necker-Enfants Malades, Paris, France

Knockout (KO) mice have been created that carry null mutations of genes encoding molecules essential for prolactin (PRL) release, PRL, the receptor for prolactin (PRLR), and various members of the receptor’s signaling pathway. This allowed an in vivo genetic analysis of the role of PRL in target organ function. In PRLKO and PRLRKO mice, mammary ductal side branching was absent, terminal end bud (TEB)-like structures persisted at the ductal termini well into maturity, and no alveolar buds formed along the ductal tree. Transplants of recombined mammary glands formed from stromal and epithelial elements with and without PRLR showed normal development, while supplementation of progesterone levels in PRLKO animals restored ductal side branching. During pregnancy, PRLR heterozygous animals initially showed normal ductal and alveolar development. However, alveolar development stalled during late pregnancy, preventing successful lactation. This defect could be rescued by the loss of a single allele of the suppressor of cytokine signaling (SOCS) 1 gene. Transplants of recombined glands containing PRLRKO epithelium and wild-type (WT) stroma formed alveolar buds during pregnancy but showed no lobuloalveolar development. Recombinations of WT epithelium and PRLRKO stroma showed normal development, demonstrating that a direct action of the lactogenic hormones is confined to the epithelium, to promote lobuloalveolar development. Transcript profiling of epithelial transplants expressing or not expressing PRLR was used during early pregnancy to investigate the transcriptional response to lactogens underlying this defect. Such profiling has identified a number of genes with well-characterized roles in mammary development, in addition to a number of novel transcripts.




This article has been cited by other articles:


Home page
J EndocrinolHome page
J. F Trott, K. C Horigan, J. M Gloviczki, K. M Costa, B. A Freking, C. Farmer, K. Hayashi, T. Spencer, J. E Morabito, and R. C Hovey
Tissue-specific regulation of porcine prolactin receptor expression by estrogen, progesterone, and prolactin
J. Endocrinol., July 1, 2009; 202(1): 153 - 166.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
R. L. Bogorad, C. Courtillot, C. Mestayer, S. Bernichtein, L. Harutyunyan, J.-B. Jomain, A. Bachelot, F. Kuttenn, P. A. Kelly, V. Goffin, et al.
Identification of a gain-of-function mutation of the prolactin receptor in women with benign breast tumors
PNAS, September 23, 2008; 105(38): 14533 - 14538.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
H. L. LaMarca and J. M. Rosen
Hormones and Mammary Cell Fate--What Will I Become When I Grow Up?
Endocrinology, September 1, 2008; 149(9): 4317 - 4321.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
S. R. Oakes, M. J. Naylor, M.-L. Asselin-Labat, K. D. Blazek, M. Gardiner-Garden, H. N. Hilton, M. Kazlauskas, M. A. Pritchard, L. A. Chodosh, P. L. Pfeffer, et al.
The Ets transcription factor Elf5 specifies mammary alveolar cell fate
Genes & Dev., March 1, 2008; 22(5): 581 - 586.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
N. Ben-Jonathan, C. R. LaPensee, and E. W. LaPensee
What Can We Learn from Rodents about Prolactin in Humans?
Endocr. Rev., February 1, 2008; 29(1): 1 - 41.
[Abstract] [Full Text] [PDF]


Home page
Endocr Relat CancerHome page
F. Doll, J. Pfeilschifter, and A. Huwiler
Prolactin upregulates sphingosine kinase-1 expression and activity in the human breast cancer cell line MCF7 and triggers enhanced proliferation and migration
Endocr. Relat. Cancer, June 1, 2007; 14(2): 325 - 335.
[Abstract] [Full Text] [PDF]


Home page
ReproductionHome page
A. Bachelot and N. Binart
Reproductive role of prolactin
Reproduction, February 1, 2007; 133(2): 361 - 369.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
C. Stocco, C. Telleria, and G. Gibori
The Molecular Control of Corpus Luteum Formation, Function, and Regression
Endocr. Rev., February 1, 2007; 28(1): 117 - 149.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
J. Harris, P. M. Stanford, K. Sutherland, S. R. Oakes, M. J. Naylor, F. G. Robertson, K. D. Blazek, M. Kazlauskas, H. N. Hilton, S. Wittlin, et al.
Socs2 and Elf5 Mediate Prolactin-Induced Mammary Gland Development
Mol. Endocrinol., May 1, 2006; 20(5): 1177 - 1187.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
L. M. Arendt, T. A. Rose-Hellekant, E. P. Sandgren, and L. A. Schuler
Prolactin Potentiates Transforming Growth Factor {alpha} Induction of Mammary Neoplasia in Transgenic Mice
Am. J. Pathol., April 1, 2006; 168(4): 1365 - 1374.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Z. Nouhi, N. Chughtai, S. Hartley, E. Cocolakis, J.-J. Lebrun, and S. Ali
Defining the Role of Prolactin as an Invasion Suppressor Hormone in Breast Cancer Cells
Cancer Res., February 1, 2006; 66(3): 1824 - 1832.
[Abstract] [Full Text] [PDF]


Home page
J DAIRY SCIHome page
E. H. Wall, T. L. Auchtung-Montgomery, G. E. Dahl, and T. B. McFadden
Short Communication: Short-Day Photoperiod During the Dry Period Decreases Expression of Suppressors of Cytokine Signaling in Mammary Gland of Dairy Cows
J Dairy Sci, September 1, 2005; 88(9): 3145 - 3148.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
M. J. Naylor, S. R. Oakes, M. Gardiner-Garden, J. Harris, K. Blazek, T. W. C. Ho, F. C. Li, D. Wynick, A. M. Walker, and C. J. Ormandy
Transcriptional Changes Underlying the Secretory Activation Phase of Mammary Gland Development
Mol. Endocrinol., July 1, 2005; 19(7): 1868 - 1883.
[Abstract] [Full Text] [PDF]


Home page
J DAIRY SCIHome page
E. H. Wall, T. L. Auchtung, G. E. Dahl, S. E. Ellis, and T. B. McFadden
Exposure to Short Day Photoperiod During the Dry Period Enhances Mammary Growth in Dairy Cows
J Dairy Sci, June 1, 2005; 88(6): 1994 - 2003.
[Abstract] [Full Text] [PDF]


Home page
J DAIRY SCIHome page
T. L. Auchtung, A. G. Rius, P. E. Kendall, T. B. McFadden, and G. E. Dahl
Effects of Photoperiod During the Dry Period on Prolactin, Prolactin Receptor, and Milk Production of Dairy Cows
J Dairy Sci, January 1, 2005; 88(1): 121 - 127.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2003 by the The Endocrine Society.